Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_4
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Recruiting2
Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

recruiting240%
withdrawn120%
completed240%

Recent Activity

2 active trials
Showing 5 of 5
recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

NCT07083557
recruiting

Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)

NCT06286761
withdrawnphase_4

Neural Mechanism of Aldosterone-induced Insulin Resistance

NCT02102243
completedphase_4

Phosphate Lowering in CKD Trial

NCT02209636
completedphase_4

Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients

NCT01501929

Clinical Trials (5)

Showing 5 of 5 trials
NCT07083557

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Recruiting
NCT06286761

Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)

Recruiting
NCT02102243Phase 4

Neural Mechanism of Aldosterone-induced Insulin Resistance

Withdrawn
NCT02209636Phase 4

Phosphate Lowering in CKD Trial

Completed
NCT01501929Phase 4

Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5